Literature DB >> 12143350

Concept of activity-induced cell death in epilepsy: historical and contemporary perspectives.

Brian S Meldrum1.   

Abstract

Selective neuronal loss following status epilepticus was first described just under 100 years ago. The acute pathology following status epilepticus was shown to be 'ischemic cell change' and was assumed to arise through hypoxia/ischemia. Less than 30 years ago it was proposed, from experiments in primates, that the selective neuronal loss in hippocampus and cortex resulted from the abnormal electrical discharges. Selectively vulnerable neurons show swollen, calcium-loaded mitochondria in the soma and focally in dendrites. Burst firing with a massive Ca2+ entry needs to be sustained for 30-120 min to produce necrotic cell death. Lesser stress may produce apoptosis or immediate early gene expression with enhanced expression of many enzymes and receptor subunits. Changes in enzyme, transporter, ion-channel or receptor function or in network properties may lead to altered vulnerability to the effects of seizures. This type of modification and the cumulative effect of oxidative damage to proteins and lipids may explain the long-term consequences of repetitive brief seizures.

Entities:  

Mesh:

Year:  2002        PMID: 12143350     DOI: 10.1016/S0079-6123(02)35003-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  36 in total

1.  Electroconvulsive shock induces neuron death in the mouse hippocampus: correlation of neurodegeneration with convulsive activity.

Authors:  I I Zarubenko; A A Yakovlev; M Yu Stepanichev; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2005-09

2.  Do single seizures cause neuronal death in the human hippocampus?

Authors:  Luisa L Rocha; Maria-Leonor Lopez-Meraz; Jerome Niquet; Claude G Wasterlain
Journal:  Epilepsy Curr       Date:  2007 May-Jun       Impact factor: 7.500

3.  Adult neurogenesis in the mouse dentate gyrus protects the hippocampus from neuronal injury following severe seizures.

Authors:  Swati Jain; John J LaFrancois; Justin J Botterill; David Alcantara-Gonzalez; Helen E Scharfman
Journal:  Hippocampus       Date:  2019-01-23       Impact factor: 3.899

4.  Contributions of astrocytes and CO to pial arteriolar dilation to glutamate in newborn pigs.

Authors:  Charles W Leffler; Helena Parfenova; Alexander L Fedinec; Shyamali Basuroy; Dilyara Tcheranova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-04       Impact factor: 4.733

5.  Electroencephalography and behavior patterns during experimental status epilepticus.

Authors:  Ewa Lewczuk; Suchitra Joshi; John Williamson; Mouna Penmetsa; Sarah Shan; Jaideep Kapur
Journal:  Epilepsia       Date:  2017-12-06       Impact factor: 5.864

6.  Glutamate regulates Ca2+ signals in smooth muscle cells of newborn piglet brain slice arterioles through astrocyte- and heme oxygenase-dependent mechanisms.

Authors:  Qi Xi; Edward Umstot; Guiling Zhao; Damodaran Narayanan; Charles W Leffler; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

7.  Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus.

Authors:  Matthew Ferguson; Matt T Bianchi; Raoul Sutter; Eric S Rosenthal; Sydney S Cash; Peter W Kaplan; M Brandon Westover
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 8.  Cerebroprotective functions of HO-2.

Authors:  Helena Parfenova; Charles W Leffler
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Automated cell-specific laser detection and ablation of neural circuits in neonatal brain tissue.

Authors:  Xueying Wang; John A Hayes; Maria Cristina D Picardo; Christopher A Del Negro
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

10.  Hypoxia markers are expressed in interneurons exposed to recurrent seizures.

Authors:  Fabio Gualtieri; Carla Marinelli; Daniela Longo; Matteo Pugnaghi; Paolo F Nichelli; Stefano Meletti; Giuseppe Biagini
Journal:  Neuromolecular Med       Date:  2012-10-17       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.